NEI
ADMA icon

Northwest & Ethical Investments’s ADMA Biologics ADMA Stock Holding History

Northwest & Ethical Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,300
Closed -$13K – 501
2025
Q3 		$13K Buy
+44,300
New +$759K ﹤0.01% 497

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northwest & Ethical Investments's ADMA Position: Q1 2026 in Review

Northwest & Ethical Investments sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 13,202 shares — an estimated $242K sold.

Northwest & Ethical Investments first reported a position in ADMA in Q1 2025 and held it in 4 quarters. The position peaked at $425K in Q2 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Northwest & Ethical Investments reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Northwest & Ethical Investments sold 13,202 ADMA Biologics shares in Q1 2026, an estimated $242K.
  • Northwest & Ethical Investments first reported a position in ADMA Biologics in Q1 2025 and held it in 4 quarters.
  • Northwest & Ethical Investments's ADMA Biologics position peaked at $425K in Q2 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.